Muscle-specific overexpression of human lipoprotein lipase in mice causes increased intracellular free fatty acids and induction of peroxisomal enzymes

Biochimie

Volumn 79, Issue 2-3, 1997, Pages 163-168

  Hoefler, G ^a   Noehammer, Ch ^a   Levak Frank, S ^a   El Shabrawi, Y ^a   Schauer, S ^a   Zechner, R ^a   Radner, H ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

B oxidation; Free fatty acids; Lipoprotein lipase; Myopathy; Peroxisomes; Transgenic mouse model

Indexed keywords

ACYL COENZYME A; CATALASE; CREATINE KINASE; FATTY ACID; GLYCOGEN; LIPOPROTEIN LIPASE; MESSENGER RNA; MUSCLE ENZYME; SUCCINATE DEHYDROGENASE; TRIACYLGLYCEROL;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; HEART MUSCLE; HUMAN; MOUSE; MUSCLE ATROPHY; MUSCLE MITOCHONDRION; MYOPATHY; NONHUMAN; PEROXISOME; PROMOTER REGION; SKELETAL MUSCLE; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 0030858781     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(97)81509-X     Document Type: Article

References (23)

1. Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis J Lipid Res 37, 693-707
2. Olivecrona T, Bengtsson-Olivecrona G (1987) Triglyceride lipases and atherosclersis In: Lipoprotein Lipase (Borensztajn J, ed) Evener/Chicago, 15-25
3. Olivecrona T, Bengtsson-Olivecrona G (1993) Opin Lipidol 4, 187-196
4. Brunzell JD (1989) Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome In: The Metabolic Basis of Inherited Disease (Scriver RS, Beaudet AL, Sly WS, Valle D, eds) McGraw and Hill, New York, 1165-1180
5. Reddy JK, Warren JR, Reddy MK, Lalwani ND (1982) Hepatic and renal effects of peroxisome proliferators: Biological implications. Ann NY Acad Sci 386, 460-466
6. Lock EA, Mitchell AM, Elcombe CR (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29, 145-163
7. Green S (1995) PPAR: a mediator of peroxisome proliferator action. Mutat Res 333, 101-109
8. Levak-Frank S, Radner H, Walsh A, Stollberger R, Knipping G, Hoefler G, Sattler W, Weinstock PH, Breslow JL, Zechner R (1995) Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest 96, 976-986
9. Zechner R (1990) Rapid and simple isolation procedure for lipoprotein lipase from human milk. Biochim Biophys Act 104, 20-25
10. Peters TJ, Muller M, de Duve C (1972) Lysosomes of the arterial wall I Isolation and subcellular fractionation of cells from normal rabbit aorta. J Exp Med 136, 1117-1127
11. Pennington RJ (1961) Biochemistry of dystrophic muscle: Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 80, 649-654
12. Roels F, Verdonck V, Pauwels M, DeCatte L, Lissens W, Liebaers I, Elleder M (1987) Light microscopic visualization of peroxisomes and plasmalogens in first trimester chorionic villi. Prenatal Diagnosis 7, 525-530
13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
14. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JD, Smith JA, Struhl K (1987) Current Protocols. In: Molecular Biology. Greene & Wiley Interscience, New York
15. Schuder JM, May R, Shin YS, Sigmund M, Nase-Hoppmeier S (1993) Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol 85, 419-430
16. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650
17. Göttlicher M, Widmark E, Li Q, Gustafsson JA (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89, 4653-4657
18. Keller H, Dreyer C, Medin J, Mahfoudi C, Ozato K, Wahli W (1993) Peroxisome proliferator-activated receptors and lipid metabolism. Proc Natl Acad Sci USA 90, 2160-2164
19. Bocos C, Gottlicher M, Gearing K, Banner C, Enmark E, Teboul M, Crickmore A, Gustafsson JA (1995) Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J Steroid Biochem Mol Biol 53, 467-73
20. Vidal-Puig A, Jimenez-Linad M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97, 2553-2561
21. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15, 3012-3022
22. Lazarow PB, Moser HW (1989) Disorders of peroxisome biogenesis. In: The Metabolic Basis of Inherited Disease (Scriver RS, Beaudet AL, Sly WS, Valle D, eds) McGraw and Hill, New York, 1479-1510
23. Schram AW, Strijland A, Hashimoto T, Wanders RJ, Schutgens RB, van-den-Bosch H, Tager JM (1986) Biosynthesis and maturation of peroxisomal beta-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci USA 83, 6156-6158